Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular ATP synthesis is the fundamental process by which living cells convert energy from nutrients into adenosine triphosphate (ATP), the universal chemical energy carrier. This process primarily involves glycolysis, the Krebs (citric acid) cycle, and oxidative phosphorylation at the mitochondrial inner membrane, orchestrated by large protein complexes (e.g., ATP synthase, electron transport chain)[1][3][4]. ATP is continuously generated and hydrolyzed to support all energy-requiring cellular functions, including active transport, synthesis of nucleic acids and proteins, and mechanical work such as muscle contraction[1][5][6]. Disruption of ATP synthesis leads to energy failure, triggering cell injury and is involved in the pathogenesis of numerous diseases, especially those affecting mitochondria, heart, brain, and muscles[1].
Inhibition of ATP synthase or electron transport chain complexes; Disruption of mitochondrial membrane potential; Promotion of uncoupling (e.g., by uncoupling agents like dinitrophenol)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular ATP synthesis.